1-10 of 10
Keywords: Glioblastoma
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Stereotact Funct Neurosurg (2020) 98 (3): 167–175.
Published Online: 03 April 2020
...Gokhan Yaprak; Naciye Isık; Cengiz Gemici; Melike Pekyurek; Beyhan Ceylaner Bıcakcı; Fatih Demircioglu; Necati Tatarlı Background: Glioblastoma (GBM) is a dismal disease. Recurrence is inevitable despite initial surgery and postoperative temozolomide (TMZ) and radiotherapy. Salvage surgery...
Journal Articles
Journal Articles
Journal Articles
Stereotact Funct Neurosurg (1995) 65 (1-4): 167–170.
Published Online: 16 October 1996
... regarding the efficacy compared to historical controls for patients with de novo and recurrent malignant gliomas and metastases. Two randomized studies for patients with de novo malignant astrocytoma and glioblastoma are nearing completion. Based on the authors'' personal experience with 115 patients...
Journal Articles
Stereotact Funct Neurosurg (1994) 63 (1-4): 154–159.
Published Online: 11 April 1995
...R. Kuroda; F. Akai; H. Iwasaki; J. Nakatani; T. Uchiyama; M. Ioku; I. Kaetsu For patients with nonresectable glioblastoma (GB) or recurrent GB, we have recently been using an interstitial chemotherapy with biodegradable polylactic acid pellets containing nimustine chloride (ACNU), in combination...
Journal Articles
Stereotact Funct Neurosurg (1994) 63 (1-4): 233–240.
Published Online: 11 April 1995
...J.E. Masciopinto; A.B. Levin; M.P. Mehta; B.S. Rhode From February 1989 to August 1992, 26 patients who presented with an initial pathological diagnosis of glioblastoma multiforme underwent tumor debulking (17) or biopsy (9), stereotactic radiosurgery (SR) and standard radiation therapy (dose range...
Journal Articles
Journal Articles
Stereotact Funct Neurosurg (1992) 59 (1-4): 157–165.
Published Online: 18 September 1992
.... For previously untreated patients who underwent external beam radiation therapy followed by implant boost, median survival from the date of diagnosis was 88 weeks for 34 patients with glioblastoma multiforme (GM) and 157 weeks for 29 patients with nonglioblastoma gliomas (NGM). For recurrent tumors treated...
Journal Articles
Journal Articles
Applied Neurophysiology (1987) 50 (1-6): 183–187.
Published Online: 28 January 1988
...Robert J. Coffey; L. Dade Lunsford We analyzed the prognostic significance of tumor histology, location, treatment, and selected clinical features at presentation in 91 consecutive patients with malignant gliomas diagnosed by stereotactic biopsy. In 64 patients with glioblastoma multiforme (GBM...